Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol
about
Population Genomics and the Statistical Values of Race: An Interdisciplinary Perspective on the Biological Classification of Human Populations and Implications for Clinical Genetic Epidemiological ResearchPharmacogenomics in the clinicCardiovascular pharmacogenomics: current status and future directionsBiobanks and personalized medicinePrivacy in the Genomic EraElectronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.Genomic data in the electronic medical record: perspectives from a biobank community advisory board.Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE networkMerging Electronic Health Record Data and Genomics for Cardiovascular Research: A Science Advisory From the American Heart Association.Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.Health Orientation, Knowledge, and Attitudes toward Genetic Testing and Personalized Genomic Services: Preliminary Data from an Italian Sample.An inter-professional approach to personalized medicine education: one institution's experienceParticipant-perceived understanding and perspectives on pharmacogenomics: the Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time)Metformin pharmacogenomics: biomarkers to mechanisms.Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.Emerging roles for pharmacists in clinical implementation of pharmacogenomicsEvidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.Pragmatic and Ethical Challenges of Incorporating the Genome into the Electronic Medical Record.Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse ModelActionable clinical decisions based on comprehensive genomic evaluation in asymptomatic adults.Preemptive clinical pharmacogenetics implementation: current programs in five US medical centersNational survey and community advisory board development for a bipolar disorder biobank.Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians.Physician perspectives of CYP2C19 and clopidogrel drug-gene interaction active clinical decision support alerts.Attitudes of clinicians following large-scale pharmacogenomics implementation.Creating Shareable Clinical Decision Support Rules for a Pharmacogenomics Clinical Guideline Using Structured Knowledge Representation.The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone.Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.Other side of the coin for personalised medicine and healthcare: content analysis of 'personalised' practices in the literatureDevelopment of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencingCSER and eMERGE: current and potential state of the display of genetic information in the electronic health record.Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges.Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6Evidence for extensive pleiotropy among pharmacogenes.Multidisciplinary model to implement pharmacogenomics at the point of care.Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.Systems biology approaches to adverse drug effects: the example of cardio-oncology.Empowering Mayo Clinic Individualized Medicine with Genomic Data WarehousingUsing Workflow Modeling to Identify Areas to Improve Genetic Test Processes in the University of Maryland Translational Pharmacogenomics Project
P2860
Q26765823-3D10077F-2294-4E84-8795-063043D18676Q26782786-6C63DFA2-02CA-47CC-87B7-0FAA6FD3DEAEQ26801183-9BDB6DAB-23BA-40CA-9C4A-84F2175953CFQ26866132-F1279D8B-7563-467F-8F23-5538CBAF68DAQ27316478-EFDF80D9-A39D-47AD-A43A-D748C9721937Q30234897-41B2DD62-FD32-4A0F-A852-CC491353F3BBQ30906010-68E072DF-DC00-482C-928C-C62DAB57ECFAQ31043647-AA75A07E-FF0F-4F71-A053-7BEB5BB6EE3EQ31058146-DC27525F-1B83-4070-B226-258FF91E2B2DQ31153959-DB29422B-02FC-4447-AA54-6C43612B6476Q31155511-2564528D-E7B2-489F-8D93-011F68F7B044Q33565033-5552F0FA-21CD-41FD-B730-F4D10E87EB5EQ33874771-D4EDEE4C-E898-4A99-BDED-17B1B654FEC7Q33959783-EEADA07C-92DA-451E-B162-65DCC15339E1Q34216807-AF8A56C3-EE66-444A-A4A0-1626A33E777FQ34302434-933234FC-3133-4CA6-9BE7-C87092CD6EFBQ35762508-E5D61DA5-13B7-4A8F-8851-74F3F3285FD1Q35809920-4F60A5CC-B02A-4CA2-B129-FD667B1A0049Q35954058-73A91649-71EE-4130-9337-FFB40FAB02C9Q36098646-C1C24F44-02A9-4BDF-9EBC-3D991E22BDC7Q36166107-E36A9B50-AFB5-443A-839F-4E45F2094E40Q36275964-359A191B-051C-4129-93B7-708DAB2BF330Q36438790-43D3BF6D-31DB-474F-A254-C871D7CEFA89Q36440277-6309CB0B-5E20-4029-9EC4-F4AEFE13820BQ36573086-03F350F0-008E-4FFC-A759-D474B3AC2D7CQ36613405-A4326275-0EE5-4CAD-8B47-634460D62B3AQ36794572-1D55E85A-89AA-4391-9AB4-9FC3695B7D76Q36853552-58A0E315-9359-4109-BAB2-95DC6D4D715AQ37100793-368D62C4-BA85-4A15-B20B-7D8650D7A653Q37156736-51622E33-74E7-470F-A4C8-8F990385658DQ37229202-822FCF20-A403-421B-967A-E3621869CB2FQ37433329-760D8B25-0DE7-48B8-901F-91DFD726308CQ37643815-DCC02A0A-2504-4136-8595-7DF1D7C6E022Q37653051-CD1F135D-6206-4E94-99B9-71F432EE7DFBQ37703583-8F579569-FD65-4D47-A9C2-CF75C2CA9BE2Q37716307-77425756-9A94-434D-AE94-A387CE33158DQ38226775-9921ACD5-84DB-4D4A-B94E-E8812051778DQ38606067-F0D2B78E-27C4-4DCB-9529-A70DE1B0764FQ38614381-AA337D21-39D6-4ED1-8808-DF57C75B2D28Q38615227-855A80E6-74EB-4E0A-AACF-E825840C3F8A
P2860
Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Preemptive genotyping for pers ...... dividualize treatment protocol
@ast
Preemptive genotyping for pers ...... dividualize treatment protocol
@en
type
label
Preemptive genotyping for pers ...... dividualize treatment protocol
@ast
Preemptive genotyping for pers ...... dividualize treatment protocol
@en
prefLabel
Preemptive genotyping for pers ...... dividualize treatment protocol
@ast
Preemptive genotyping for pers ...... dividualize treatment protocol
@en
P2093
P2860
P50
P1476
Preemptive genotyping for pers ...... dividualize treatment protocol
@en
P2093
Carolyn R Rohrer Vitek
Christopher G Chute
Cloann G Schultz
Eric D Wieben
Eric W Klee
Euijung Ryu
Gianrico Farrugia
Iftikhar J Kullo
Jamie K Bruflat
Jason L Ross
P2860
P356
10.1016/J.MAYOCP.2013.10.021
P407
P577
2014-01-01T00:00:00Z